Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Skin cancer, melanoma
Stage/Subtype:  stage II melanoma
Trial Type:  Treatment
Results 1-14 of 14 for your search:
Start Over
Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 to 75
Trial IDs: 10-000062, NCI-2013-00645, 10-001674, 11-002177, NCT01826864
MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
Status: Active
Phase: Phase III
Type: Health services research, Treatment
Age: 18 and over
Trial IDs: ANZMTG 03.12, NCI-2016-00246, NCT02385214
A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: GCO 14-0780, NCI-2016-01809, NCT02334735
Pembrolizumab in Treating Patients with Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: S1512, NCI-2016-00666, NCT02775851
Proton Beam or Photon-Based Intensity-Modulated Radiation Therapy in Treating Patients with Salivary Gland Cancer, Skin Cancer, or Melanoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 16-1416, NCI-2016-01575, NCT02923570
Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: ALS-357-001, NCI-2010-01853, NCT00701987
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BBI-DSP7888-101, NCI-2015-01357, NCT02498665
Phase 1 Study of GRN-1201 in HLA-A*02 Subjects With Resected Melanoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: GRN1201-001, NCI-2016-01132, NCT02696356
X4P-001 and Pembrolizumab in Patients With Advanced Melanoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: X4P-001-MELA, NCI-2016-01133, NCT02823405
Recombinant Interferon Alfa-2b or PEG-Interferon Alfa-2b in Treating Patients With Melanoma Undergoing Sentinel Lymph Node Biopsy
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 08-067, NCI-2011-02485, NCT00871533
Neurotropic Melanoma of the Head and Neck
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: ANZMTG 01.09, NCI-2015-00466, 2009/039, ACTRN12610000478011, TROG 08.09, NCT00975520
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients with Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: I 229812, NCI-2013-01198, NCT01896778
Ipilimumab and Radiation Therapy in Treating Patients with High-Risk of Recurrence or Locally Advanced Melanoma
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: Pro00045042, NCI-2014-00258, BMS 184-234, NCT01996202
Wide Local Excision with 1 cm or 2 cm Margins in Treating Patients with Melanoma
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: IIT-2016-JM-MEL-T2Margins, NCI-2017-00407, STUDY00140148, NCT03034395
Start Over